GlassScriptPhysician profile
Alexander Rabinovich
NPI 1245411743
$2,640.87
in general payments reported to CMS, 2019-2025
22 companies · $433 in 2025
The $433 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $260 · 2020: $64.98 · 2021: $64.26 · 2022: $461 · 2023: $845 · 2024: $512 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,790.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $682.88 | 2019-2023 | Tepezza |
| Amgen INC. | $460.42 | 2024-2025 | Tepezza |
| Oyster Point Pharma, INC. | $276.03 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Allergan, INC. | $168.50 | 2019 | |
| Bausch & Lomb Americas INC. | $156.60 | 2023-2025 | Xiidra, Prolensa, Vyzulta |
| Sun Pharmaceutical Industries INC. | $147.45 | 2022-2025 | Cequa |
| Novartis Pharmaceuticals Corporation | $124.13 | 2021-2023 | |
| Alcon Vision LLC | $91.29 | 2022-2023 | Simbrinza |
| Astellas Pharma US INC | $66.98 | 2025 | Izervay |
| Merz Pharmaceuticals, LLC | $53.62 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $50.92 | 2024-2025 | Xdemvy |
| Merz North America, INC. | $50.62 | 2019-2020 | |
| Glaukos Corporation | $49.35 | 2023 | |
| Stryker Corporation | $38.94 | 2019 | |
| Sandoz INC. | $34.97 | 2024 | Cimerli |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $33.48 | 2024 | Vevye |
| Dompe US, INC. | $28.56 | 2022 | |
| Rxsight INC | $28.53 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Mallinckrodt Hospital Products INC. | $28.46 | 2025 | Acthar |
| Regeneron Healthcare Solutions, INC. | $23.81 | 2023 | Libtayo |
| Biotissue Holdings INC. | $23.33 | 2023 | |
| Eyevance Pharmaceuticals LLC | $22.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Rabinovich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.